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Background: Dialectical behavior therapy (DBT) has been proven to be an efficacious treatment for borderline
personality disorder (BPD) in several randomized controlled trials (RCTs). However, generalizability of this outcome
to the routine health care (effectiveness) has rarely been investigated to date. The aim of this study is to examine
the effectiveness of DBT for BPD under the routine health care situation in Germany.
Methods: The study has a longitudinal design over a course of four years with six assessment points. In this paper,
results for the first year of treatment are reported. Outcome was assessed at four times throughout an initial phase
(of up to five therapy-sessions) and an additional 12 months of therapy. Overall, n =78 patients started the study,
47 patients completed one year of treatment. Dependent variables were number and duration of inpatient treatment
stays, number of suicide attempts and non-suicidal self-injury, severity of borderline symptoms, depression, level of
dissociation, and general psychopathology.
Results: Patients significantly improved regarding self-injurious behaviors, number of inpatient hospital stays, severity
of borderline symptoms and psychopathology. At the end of the first treatment year, 77% of the patients no longer
met criteria for BPD diagnosis. Fewer therapy discontinuations by patients were observed when therapists participated
in consultation teams.
Conclusions: Under routine mental health care conditions in Germany, outpatient DBT leads to positive results
comparable to those reported in other effectiveness studies and in randomized controlled trials.
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A number of randomized controlled trials (RCTs) have
demonstrated the efficacy of outpatient dialectical
behavior therapy (DBT) [1] for the treatment of patients
with borderline personality disorder (BPD) [2-11]. Five of
these studies compared DBT with treatment-as-usual
(TAU) [2-6], one study with a client-centered approach
[7], one study with TFP and supportive therapy [10] and
two other studies with treatment by experts [8,9]. Except
for the studies by Feigenbaum et al. [2], McMain et al. [9],
and Clarkin et al. [10], only female participants were* Correspondence: christian.stiglmayr@awp-berlin.de
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unless otherwise stated.included in these trials. In the study by Feigenbaum et al.
[2] patients with BPD as well as patients with another
Cluster B personality disorder were included, with the
majority (92%) meeting BPD criteria. In these studies,
length of treatment varied between 6 and 12 months. In
their meta-analysis, Stoffers et al. [11] conclude that DBT
is the only approach developed for the treatment of
borderline patients with several RCT comparison studies
available. Thus, evidence-based treatment guidelines
including those from the American Psychological
Association and the German S2-Guidelines assign the
highest empirical evidence for DBTas a treatment approach
for BPD [12,13].
DBT has proven especially effective in reducing
self-injuriousbehavior, suicide attempts and inpatiental Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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with DBT showed a marked reduction of disorder-related
direct and indirect monetary costs [14-17].
For several reasons, generalizability of RCTs to the
actual routine health care situation is limited. While
efficacy-studies – usually with high internal validity -
answer the question whether a specific intervention
works for a specific clinical problem, effectiveness aim to
investigate how a certain treatment approach works
under clinical routine circumstances and thus enlarges
the external validity.
In order to transfer results of RCT studies to routine
clinical care, a three-phased program for the evaluation
of psychotherapy has been proposed: a pilot phase (stage 1)
followed by RCTs with the aim to investigate the efficacy
of a treatment form (stage 2) and the conduction of
effectiveness studies under routine clinical settings
(stage 3) e.g. [18]. Accordingly, the necessity of effectiveness
studies has also been emphasized for the treatment of
borderline patients, e.g. [19-22]. Several studies were
conducted investigating effectiveness of DBT under
routine health care conditions [23-27]. Results indicate high
effectiveness of the treatment, mostly based on report of
pre-post changes of relevant outcome variables. So far, a
study by Friedrich and colleagues [25] is the sole German
effectiveness-study showing positive outcome for outpatient
DBT. Conclusions from this study are limited, however,
because only patients whose health insurance covered
an unusually high number of individual therapy ses-
sions and skills group sessions were included in this
trial. Therapy with borderline patients is regarded as
particularly challenging for therapists [28-30]. Therefore,
weekly consultation team meetings are an essential part of
DBT. Besides the prevention of burnout, the additional goal
of consultation team meetings is to ensure DBT treatment
adherence. To our knowledge, the impact of concurrent
supervision and consultation team meetings on therapy
course and outcome has not yet been explored.
The aim of the current study was to investigate the
effectiveness of DBT with BPD patients under routine
mental health care conditions in Germany. In Germany,
DBT is mostly offered within existing networks of therapists
and institutions. Our study was conducted within the Berlin
borderline network and thus also serves as an evaluation
of such a network. Based on other publications on the
effectiveness of DBT, we expected positive outcome
for the following parameters: number and duration of
inpatient stays, frequency of suicide attempts, fre-
quency of self-injurious behaviors, extent of borderline
symptomatology and reduction of general and specific
psychopathology. In addition, we explored whether par-
ticipation of therapists in concurrent supervision and con-
tinuous attendance of consultation teams were related to
premature termination of therapy.Methods
Study design and procedure
The current study has a longitudinal design with a total of
six assessment times over a period of four years. Here,
results for the first treatment year with four assessment
times are reported. Within the German health care system
five initial sessions of psychotherapy are always covered by
health insurances. This initial phase was added to the
one year of therapy. The treatment was provided by
psychotherapists in private practice, all trained in DBT
(more information on therapists is provided below).
Subsequent to a telephone screening, possible partici-
pants were invited to participate in an extensive diagnostic
assessment procedure (t0). A team of trained master-level
psychologists conducted the telephone screening as well as
the diagnostic procedure. All participants gave informed
consent for participation. The study was approved by the
ethics committee of Charité Berlin.
Patients who met inclusion criteria (see below) were
referred to one of the participating therapists. Additional
assessment points were: (t1) after the initial phase of
treatment (first five sessions), and at 4 months (t2) and
12 months after t1 (t3). Follow-up assessments at 24 and
48 months are planned but are not part of the presented
analyses. Patients had the opportunity to continue with
DBT after t3.
The median number of days between enrolment
(t0) and t1 was 120 days. This time included the applica-
tion process for coverage of treatment costs by the health
insurance as well as the first 5 therapy sessions. In routine
psychotherapeutic care in Germany this process takes
about 2-3 months. The rather large range was due to
limited capacities of the therapists, problems in finding an
appointment for the first therapy session or to patients not
showing up at the arranged dates. The initial phase (five
sessions; see above) was held prior to assessment of t1.Participants
Patients were recruited through a network of in- and
outpatient clinicians and institutions as well as training
programs and community mental health centers. When
interested, patients received a note including a short
description of the study and the telephone number of
the study center. Furthermore, a homepage referred to the
study (www.borderline-netzwerk-berlin.de).
Inclusion criteria were a current diagnosis of borderline
personality disorder (BPD) according to DSM-IV-TR [31]
as assessed by SCID-II [32] and a minimum age of 16 years.
Exclusion criteria were lifetime diagnoses of schizophrenia,
bipolar I disorder, acute suicidality, substance dependence
within the last six months, a body-mass-index lower
than 18 and an IQ lower than 80 as well as presence of a
diagnosis of antisocial personality disorder. Additionally,
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ongoing psychotherapy.
N =238 individuals interested in participation were
screened by phone (see Figure 1). 152 patients were
invited for further assessment; 56 did not meet inclusion
criteria. Due to the limited capacities of available DBT
therapists, 18 patients meeting inclusion criteria wereFigure 1 Participant Flow.not treated within a DBT protocol but were rather
referred to other CBT therapists. Those patients did
not differ significantly in relevant characteristics (age,
gender, severity of borderline symptoms) from the
DBT patients. As our aim was to focus on treatment
outcome for DBT in a naturalistic setting, data of
these 18 patients were not included in this report. Of













No formal education 1 2.1
9 years 4 8.5
10 years 28 59.6
High-school 14 29.8
Family status
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diagnostic procedure (t0) eight did not start treatment
(non-starter); thus 70 patients (59 female) started DBT
treatment. Seventeen patients dropped out of treatment.
Following the DBT rules within the Berlin borderline
network, patients were considered dropouts when they
missed four or more consecutive scheduled sessions.
Further six patients did not provide data at 12-month
assessment time and discontinued study participation.
Therefore, n =47 patients (43 female) completed the
one-year treatment and provided data (see Figure 1).
Table 1 shows sociodemographic as well as clinical
variables of the n =47 participants at t0. Participants had
a mean age of 30.1 years (SD =8.1). Four of the 47
participants were male (8.5%). The mean number of
diagnostic criteria met for BPD was 6.5 (SD =1.2). On
average, patients had more than two additional Axis I
disorders (range 0–7) and more than one additional
personality disorder (range 0–4). The median number
of psychotropic medications was 2 (range 0–7).Single 18 38.3
Married or in a steady relationship 29 61.7
Occupational status








Other psychotropic medication 24 51.1
Comorbid disorders (current)
Any depressive disorder 18 38.3
Panic disorder w agrophobia 7 14.9
Social phobia 11 23.4
Obsessive compulsive disorder 3 6.4
PTSD 17 36.2
Other anxiety disorder 11 23.4
Any anxiety disorder 29 61.7
Eating disorder 17 36.3
Substance abuse 12 25.5
Any Axis-I disorder 43 91.5
Other personality disorder 32 68.1Treatment and therapists
Treatment was offered within the already existing network
of therapists and institutions, the Berlin borderline
network. In line with the recommendations by Linehan [1],
DBT within this network consisted of a weekly individual
therapy session (50 min) and a weekly skills group training
session (120 min). In addition, treatment elements included
telephone contacts between the individual therapist and
the patient, foremost for crisis intervention, as well as
a consultation team meeting (60 min) at least once
every week for up to five individual therapists in which
treatment for the patients was discussed and planned.
Supervision was offered throughout to all therapists
and was conducted by a certified DBT supervisor
(CS); participation was voluntary.
The mean number of therapy sessions was 38.5 (n =47;
SD =9.2; range 17–55). As part of the study, six DBT skills
groups were offered. Of the 47 patients at t3, 42 (89.4%)
attended the skills training over an average of 18.9
sessions (SD =10.0; min =12 max =36).
DBT therapists were recruited via the Berlin borderline
network. Therapists had attended at least 64 hours of
DBT training at an institute for DBT training certified by
Linehan. A requirement for the skills trainers was that one
of them had conducted all skills training modules at least
once before. All individual therapists had a medical or
psychological background and were required to have the
psychotherapy state license (German: Approbation). All
worked in private practice and provided treatment as part
of the routine mental health care in Germany.
Treatment of the 47 patients (in square brackets infor-
mation is given for the 70 patients who were treated withDBT) was provided by 20 therapists (13 female; mean age
41.2 years, SD =6.6) [29 therapists; 22 female; mean age
40.9 years, SD =6.7]. They had an average of 13 years
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as psychotherapists and had been providing DBT on
average for 5.9 years (SD =3.4) [5.7 years, SD =3.8].
The mean number of DBT training classes attended
was 5.9 (SD =1.4) [5.5, SD =1.7]. Each therapist
treated on average 3.3 patients (SD =1.8; range 1–7)
[2.8 patients; SD =1.8, range 1–7]. Four [also 4 therapists
for the 70 patients] therapists were certified trainers in
DBT, three [also 3 therapists for the 70 patients] were
certified DBT supervisors. Seventeen therapists (85%) [22
therapists, 75.6%] attended a weekly consultation team, 16
(80%) [16 therapists, 55.2%] regular DBT supervision.
Assessment and measures
At t0 the German versions of the SCID I [33] and SCID II
[32] for DSM-IV were applied. Diagnosticians were master-
level clinical psychologists with a completed or undergoing
CBT training program, had a mean of 9.5 years of clinical
experience and had completed at least 22 hours of training
with co-authors T.F. and B.R. for the SCID interviews.
Diagnostic assessments were supervised by B.R. Interrater
reliability (intraclass correlation coefficient) for a diagnosis
of BPD diagnosis was excellent (ICC =0.96). Estimation of
patients’ level of intelligence was based on word fluency
vocabulary test (WST; [34]).
To determine the number of suicide attempts and
non-suicidal self-injury (NSSI), the Lifetime Parasuicide
Count (LPC; [35]) was conducted; number and length of
inpatient or partial inpatient stays were assessed with
a report tool developed by Wagner et al. [16,17]. To
assess severity of the borderline symptoms, the Borderline
Symptom List (BSL; [36]) and the borderline section of
SCID-II were performed at t3 again. Borderline-specific
thinking patterns were assessed by the Questionnaire of
Thoughts and Feelings (QTF; [37,38]). Further, the Brief
Symptom Inventory (BSI; [39]) was applied to assess general
psychopathology. For depression the Beck-Depression-
Inventory (BDI; [40]) and the Hamilton-Depression-
Scale were applied (HAM-D; [41]); the level of dissociative
symptoms was assessed with the Dissociation-Tension-
Scale (DSS; [42]).
Therapists’ adherence to DBT was rated with the
Adherence Coding Scale [43]. The scale comprises 66
items and allows differentiated rating of the extent
and the competence of the application of the various
DBT strategies on the part of the therapists. For each
item a score between 0 and 5 was assigned, scores ≥4
indicate the adherent application of a strategy. Prior
to the study, three raters were extensively trained by
Katie Korslund, Behavioral Research & Therapy Clinics
(BRTC), until a satisfactory calibration was achieved. In
the first three months of the treatment, two randomly
selected video-taped therapy sessions were rated for
adherence, in the following three-month periods onevideo-taped session. In total, a maximum of five video
tapes per therapy were rated for adherence. The mean
value for all rated sessions was 4.17 (only completers;
n =43; SD =0.12; range 3.78–4.41) indicating an adherent
application of DBT.
Statistical procedures
In order to analyze the short- and long-term effects of
DBT, a multilevel analysis was conducted on outcome
variables. A dummy variable coding scheme was used to
identify the three time periods under investigation: t0
to t1 (pre-assessment until start of therapy), t1 to t2
(short-term effect after 4 months) and t1 to t3 (long-term
effect after 12 months). Assessment time t1 served as a
reference category in relation to t0, t2, and t3. Dummy
variables were integrated into the multilevel model on
level 1. On level 2, the coefficient β00 describes the mean
value of the dependent variable at the onset of therapy,
the coefficient β01the mean change of the symptoms from
t0 to t1 (pre-assessment until beginning of therapy) and
so on. Assuming that changes in symptoms vary between
participants, the random effects of the difference scores
were allowed for. It is recommended to keep the random
effects at a maximum as long as there are no convergence
problems (e.g. [44]).
The equation for the multilevel was:
Level 1 yti ¼ π0i þ π1i Dummy1ti þ π2i Dummy2ti
þ π3i Dummy3ti þ eti
Level 2 π0i ¼ β00 þ u0i
π1i ¼ β10 þ u1i
π2i ¼ β20 þ u2i
π3i ¼ β30 þ u3i
For the following dependent variables the multilevel
model was computed: BDI, BSI-GSI, BSL, DSS, QTF,
HAM-D. As there was considerable variation over the
time period from pre-assessment (t0) to t1 after the
first five sessions, it was additionally controlled whether
this initial period offered a significant explanatory contri-
bution for the variability on the mean change. However,
as in none of the models a significant influence was
observed, this assessment period was not included in
the computation model.
In addition to the completer analysis, the same multilevel
model was applied for the intention-to treat (ITT) sample
(n =78). Note that n varies across outcome measures and
time points.
Besides statistical significance, effect size estimates
according to Cohen [45] (for dependent data: dz = |μz
|/σz = |μx − μy|/√(σx2 + σy2 − 2ρxy σx σy)) were com-
puted. The effect size estimates are based on the
pair-wise consideration of the assessments at t0
and t3.
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suicidal behaviors and self-injurious behavior as well as
inpatient days, it was not possible to conduct multilevel
analyses for these variables. These variables were evaluated
using non-parametric procedures. The impact of confound-
ing variables was controlled for with covariate analyses.
Results were double-checked non-parametrically with
the Wilcoxon-Test and Friedman’s analysis of variance
by ranks. Correlations were computed with Pearson’s
r, Spearman’s rho or point biserial correlations. Com-
parisons of frequency of a characteristic between two
independent samples were controlled for with the
Fisher-Yates test, for dependent variables with the
McNemar test. Nominal data were calculated by using
Χ2-test.Results
No significant difference between completers (n =47),
non-completers (n =23) and the ITT sample (n =78)
were observed regarding relevant variables (age, sex,
education, number of psychotropic medication, number
of DSM-IV-TR BPD criteria as well as the outcome vari-
ables of borderline symptomatology and psychopathology).
As shown in Table 2, significant reductions in non-
suicidal self-injury (NSSI), number and duration of inpatient
treatment stays, as well as in number of diagnostic criteria
met for BPD were observed.Suicide attempts
Six patients reported one or more suicide attempts
within the 12 months prior to the study; in the course of
the one-year treatment period only one patient reported
a suicide attempt. This participant was not one of the
6 aforementioned patients. Since most of the participants
reported no suicide attempt (mode =0); the difference from
t0 to t3 regarding suicide attempts was not statistically
significant (Table 2).Table 2 Median, range, descriptive means (Md) and standard
t0 t3
Median Range Median Ran
Number of suicide attempts .00 0-2 .00 0-
NSSI 5.17 0-901 1.00 0-1
Md SD Md S
Inpatient treatment
Number of inpatient stays 1.13 1.41 0.32 0.8
Duration (days) 51.3 74.2 6.8 19
Number of DSM-IV TR
BPD criteria met
6.4 1.2 3.2 1
Note. Effect sizes (Cohen’s d) are based on pair-wise descriptive statistics t0-t3 (p-va
Number of suicide attempts, non-suicidal self-injury, number and days of inpatient
aMcNemar-Test because of dichotomous variables (suicide attempt yes/no).NSSI
Patients showed a decrease in NSSI over time with a
small effect size (d = .33). At time of study inclusion,
15 participants reported no NSSI (32%) in the past
12 months. A total of 11 patients did not show NSSI
prior to or over the course of the data collection period
(26%; n =42). Three persons who did not report any NSSI
prior to treatment (t0) showed NSSI during the treatment
period. Due to the skewed data distribution, NSSI was
tested non-parametrically.DSM-IV TR BPD criteria
Due to missing data, SCID-II ratings for BPD features
were obtained only for n =31 participants at t3. Of those
31 patients, n =24 (77%) did no longer meet DSM-criteria
for BPD.
Neither gender nor education nor age of the patients
had a significant impact on the change in the dependent
variables between t0 and t3. Only for the number of
medications at study inclusion a positive correlation with
the changes during the one-year DBT treatment was found
with the number of days spent in inpatient treatment
(r = .33, p <0.05). Patients with a higher number of
medications showed a larger reduction in the number
of inpatient hospital days during outpatient DBT
treatment. Therefore, this variable was controlled for
when appropriate.Borderline symptoms and psychopathology
Table 3 shows results for self-reported severity of borderline
symptoms, depression, dissociation and overall symptom
severity for all assessment times. Results indicate significant
improvement on all measures with medium effect sizes
between d =0.43 and d =0.66.
As shown in Table 4, the multi-level-model implied
that mean values are very close to the descriptive statistics
per assessment time, indicating a good fit of the model to
the data.deviations (SD) for pair-wise comparisons t0–t3
Time effect
ge n (pairs) Wilcoxon U p Effect sized
1 42 1.000a
74 42 -3.03 .002 0.33
D n (pairs) t df p Effect sized
9 47 3.85 46 <.001 0.56
.9 47 4.15 46 <.001 0.61
.9 31 8.85 30 <.001 1.59
lues pair-wise Wilcoxon- and t-tests).
treatment stays 12 months prior t0 is compared to 12 months prior t3 NSSI.
Table 3 Descriptive means (Md) and standard deviations (SD) for pair-wise comparisons t0–t3
t0 t3 Time effect
Md SD Md SD n (pairs) t df p Effect size
d
BSL 2.13 0.55 1.69 0.88 37 2.97 36 .005 0.49
QTF 3.69 0.53 3.32 0.75 34 3.08 33 .004 0.53
BDI 30.9 8.6 22.4 14.3 39 4.10 38 <.001 0.66
HAM-D 11.68 4.74 9.06 6.50 31 2.40 30 .023 0.43
BSI-GSI 1.91 0.65 1.52 0.91 39 2.69 38 .010 0.43
DSS 28.5 16.2 19.6 13.9 31 3.39 30 .002 0.61
Note. Effect sizes (Cohen’s d) are based on pair-wise descriptive statistics t0-t3 (p-values obtained from pair-wise t-tests).
BSL= Borderline Symptom List.
QTF = Questionnaire of Thoughts and Feelings borderline-specific cognitions.
BDI = Beck Depression Inventory.
HAM-D = Hamilton Depression Scale.
BSI-GSI = Brief Symptom Inventory – Global Severity Index.
DSS = Dissociation-Tension-Scale.
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was analysed, and results are reported in Table 4. From the
diagnostic pre-assessment (t0) to the assessment point after
the first five sessions (t1), significant changes occurred in
self-reported depression (BDI), dissociative symptoms
(DSS), and in borderline symptoms (BSL). Regarding
the short-term effect (t1–t2) significant differences for
the BSI-GSI as well as for the HAM-D were observed. For
the period from t1 to t3 there was a significant reduction
in symptoms of depression (BDI and HAM-D), global
severity of symptoms (BSI-GSI), dissociation (DSS)
and also in borderline-specific cognitions (QTF).
The intention-to-treat analysis including n =78 patients
showed no substantial differences on any of these outcome
variables. Equally important, there were no differences in
the interpretation of the p-values at the 5% level with two
exceptions: The t0-t1 difference score for the BSL was not
significant and the t1-t3 difference score was also not
significant in the ITT sample.
In addition, reliable change and clinical significant change
were calculated following Jacobson et al. [46]. Depending on
the outcome measure, between 35.5% and 38.5% of the par-
ticipants can be considered recovered or reliably improved
in borderline symptoms and psychopathology (Table 5).Table 4 Borderline symptoms and psychopathology: descriptive m
implied means (Mm)
Md and SD
Outcome t0 t1 t2 t3
BSL 2.10 (0.54) 1.89 (0.73) 1.81 (0.74) 1.68 (0.89
QTF 3.73 (0.55) 3.62 (0.55) 3.42 (0.71) 3.25 (0.82
BDI 31.12 (8.60) 26.78 (12.24) 24.27 (10.22) 21.72 (13.97
HAMD 11.69 (4.67) 11.09 (6.31) 7.42 (4.60) 8.04 (6.11
BSI-GSI 1.92 (0.64) 1.95 (0.73) 1.64 (0.80) 1.46 (0.90
DSS 29.70 (16.35) 25.95 (19.08) 22.27 (17.26) 20.03 (16.84
Note: *** p < .001; ** p < .01; * p < .05.
P-values are based on multilevel model difference scores β10(t0-t1), β20 (t1-t2), β30 (Attendance of a concurrent supervision or consultation
team
When therapists attended the consultation team meetings,
significantly fewer patients dropped out of treatment
(Χ2 = 8.05; p < .05). No significant effect was observed for
the influence of attended supervision on the rate of
dropouts (supervision yes/no: rbis = -.23; p < .05; number
of supervision sessions: rbis = -.45; p < .01).
Discussion
The present study examined the effectiveness of out-
patient DBT under routine mental health care conditions
in Germany. As far as we know this is the second
effectiveness study ever performed in Germany regarding
outpatient DBT.
In line with results from RCTs studies on efficacy of
outpatient DBT as well as other effectiveness studies,
our findings demonstrate improvement in symptoms for
patients with borderline personality disorder over an
initial phase of treatment followed by a 12-month
treatment period in accordance with the German guide-
lines of psychotherapy. Our results indicate a reduction in
the number of non-suicidal self-injury (NSSI), the number
and duration of inpatient hospital stays, the severity ofeans (Md), standard deviations (SD) and multilevel-model
Mm Difference scores
t0 t1 t2 t3 t0-t1 t1-t2 t1-t3
) 2.09 1.90 1.87 1.70 -0.19* -0.03 -0.19
) 3.71 3.62 3.49 3.25 -0.10 -0.13 -0.36***
) 30.77 27.07 24.89 22.21 -3.70* -2.18 -4.87*
) 12.13 10.81 8.17 9.09 -1.32 -2.64*** -1.71*
) 1.92 1.93 1.67 1.49 0.01 -0.26* -0.44***
) 30.18 26.16 23.90 20.64 -4.02* -2.26 -5.52**
t1-t3) (n = 47).
Table 5 Reliable change and clinical significant change on outcome measures
BPD baseline NCS** Recovered Improved* Unchanged Deteriorated
Outcome M SD M SD CRIT n % n % n % n %
BDI (n = 39) 30,85 8,60 7,72 6,47 17,65 10 25.6 14 35.9 23 59.0 2 5.1
BSI-GSI (n = 39) 1,91 0,65 0,31 0,23 0,73 5 12.8 15 38.5 18 46.2 6 15.4
BSL (n = 37) 2,13 0,55 0,40 0,22 0,89 6 16.2 14 37.8 19 51.4 4 10.8
DSS (n = 31) 28,47 16,20 2,79 2,90 6,69 2 6.5 11 35.5 19 61.3 1 3.2
FGG (n = 34) 3,69 0,53 1,99 0,53 2,84 4 11.8 13 38.2 17 50.0 4 11.8
HAMD (n = 31) 11,68 4,74 0,91 1,04 2,85 2 6.5 11 35.5 17 54.8 3 9.7
*Note: improved category contains both improved and recovered patients.
BPD: Borderline Personality Disorder M/SD at baseline (t0).
NCS: non-clinical samples M/SD.
**Descriptives derived from: BDI [46], BSI-GSI [40], BSL [47], DSS [41], QTF [37], HAMD [48].
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global severity of symptoms (BSI). Only 23% of patients still
met diagnostic criteria for BPD according to DSM-IV-TR
after one year. It should be noted, however, that like in
other studies the level of depression and general symptom
severity improved but were still in a clinical range.
The study evaluated a therapy in a network of clinicians
and institutions working with borderline patients in Berlin.
The network was implemented in 2003 in order to improve
the situation for borderline patients seeking treatment. The
treatment approach of the network is DBT offered accord-
ing to the guidelines formulated by Linehan [1]. Except
for some of the inclusion- and exclusion criteria as well
as patient referral, all other mentioned restrictions (e.g.,
patients were considered dropouts when they missed four
or more consecutive scheduled sessions) are part of the
DBT-rules within the Berlin borderline network.
In DBT the first five sessions define the initial phase of
therapy. The main aim of this phase is getting a strong
commitment for therapy from the patient. Our data show
significant reduction of self-reported depressive symptoms
(BDI) and borderline symptom severity (BSL) in the course
of this initial phase (t0-t1) already. It should be noted that
this initial phase included in some cases quite a long
waiting time for an available therapist. Therefore, the
knowledge about the availability of a therapy even after a
long waiting period as well as further unknown variables
may have played an additional role in this improvement.
Based on the multilevel analyses, further statements
on changes in the course of therapy can be made for the
severity of borderline symptoms as well as associated
psychopathology. Significant short-term effects for the
first four months of therapy (t2) were found only for
BSI-GSI and the HAM-D. Over the complete 12 months
(t1 to t3), significant improvement was obtained for
nearly all self-reported measures assessing psychopatho-
logical symptom severity. The lack of improvement on
the BSL over the one-year period is somewhat surprising.This may be due to the improvement in borderline
symptom severity during the initial phase (t0-t1) already.
In addition to the mixed-model completer analyses, an
ITT analysis with n =78 patients was conducted. Because
the results for the ITT analysis did not differ noticeably
from those of the completer analyses, it can be assumed
that participant attrition did not substantially alter the
pattern of findings.
In comparison to the study of Bohus et al. [47] significant
change and reliable change rates are somewhat lower in
our study. Bohus et al. reported that 41.9% of the BPD
patients receiving 3 months of inpatient DBT were
clinically recovered on a general measure of psychopath-
ology [46]; in our study 38.5% of the participants receiving
one-year outpatient therapy were clinically recovered or
improved using the same self-report instrument (BSI-GSI
[39]; on average across all applied instruments: 36.9%).
Furthermore, our outcome shows a somewhat lower but
still comparable rate of improvement for BPD symptoms
and psychopathology compared to the treatment of
avoidant personality disorder (e.g. [48]).
The overall attrition rate including the patients who
prematurely terminated the study protocol but not the
therapy was 32.9%, the rate for treatment dropout only
was 24.3%. Thus the current dropout rate (32.9%) is
higher than in most other studies evaluating DBT with
BPD patients ([2-4], [6-8], [23-27]). Only in the two
studies by McMain et al. [9] and Verheul et al. [5]
the dropout rates were comparable, in the trial by
Feigenbaum et al. [2] the dropout rate was even higher
(56%). It should be noted that DBT drop-out rates are
difficult to compare between studies due to different
treatment duration and different definition of drop-out
(for a discussion see Kröger et al. 2014 [49]). Unfortunately,
the reasons for therapy or study discontinuation could only
partially be explained (see Figure 1). Almost half of
the 23 patients terminated their further participation
without giving any reasons. However, we assume that
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health care situation in Germany. In another German
sample Kroeger et al. [49] found nearly the same attrition
rate within a 3-month DBT inpatient treatment.
In our study, the additional attendance of team consulta-
tions by therapists may have served as a protection against
patients’ discontinuation of therapy. This finding confirms
the statement by Linehan according to which therapists
treating borderline patients need support on a regular basis.
However, it remains unclear whether the consultation team
attendance was decisive for the lower dropout rate or
whether it was due to a higher motivation of therapists or
other variables that were not assessed. In contrast to the
results of Pasieczny & Conner [27], the extent of DBT
training had no impact on treatment outcome. In our
opinion further research should address the influence of
these therapist-specific variables in a systematic manner.
To examine comparability to other studies, the severity
of the disorder, the dose of therapy as well as the quality of
the therapy procedure (adherence) of the different samples
should be considered. To the extent to which the measure-
ment instruments were comparable, on a descriptive level
the severity of the disorder of the participants in the current
study was similar to that reported in publications by Koons
et al. [3], Hjalmarsson et al. [26], Linehan et al. [4], McMain
et al. [9], Pasieczny & Conner [27] and Turner [7]. The
sample examined by Friedrich et al. [25] seemed somewhat
less severely impaired, the one examined by Linehan et al.
[8] more severely affected. Regarding comorbidity with
other Axis-I and/or Axis-II disorders, our sample is also
comparable with those in aforementioned publications.
Only the number of acute comorbid depressive disorders
was slightly lower than the average number in the other
studies [2,8,9,24,27]. This is also reflected in the comparably
low value of HAM-D. The extent of therapy received
was comparable to that reported in McMain et al. [9]
(individual therapy sessions: 39 vs. 32; skills group 19
vs. 26). In comparison to the study by Linehan et al.
[8] participants in the current study received slightly
less treatment (individual therapy: 39 vs. 43; skills group:
19 vs. 38). Therapists’ adherence was good with a score
of 4.17 (on a scale from 0-5) (Linehan et al. [8]: 4.0;
McMain et al. [9]: 4.06). In summary, concerning the
comparability with other treatment studies, we see no
limitations of our outcome data regarding severity of
the disorder, dose of therapy and adherence.
The pre-post effect sizes of the dependent variables
were medium in size (following the interpretation of
Cohen [45]). A small to median effect was found for
NSSI; for the number of BPD criteria a large effect
was found. To date, Comtois et al. [24] have been the
sole research team to compare their outcomes with those
of three RCTs [4,8,50], within a benchmarking design. In a
descriptive comparison, the study by Comtois et al. [24]showed similarly good results as the RCTs, with the
exception of the reduction of medically treated parasuicides
(NSSI: d =0.13; inpatient-days: d =0.55). The effect sizes of
our study, too, are comparable to those of other effective-
ness and efficacy studies. However, regarding the reduction
in NSSI our effect size is somewhat smaller [3,9,26,27], but
not as small as in the study of Comtois et al. [24].Limitations
A main limitation of our study is the large number of
missing data that may have led to biased results. Limited
financial as well as personnel resources may have discour-
aged study participants from regularly participating at the
assessment procedures to the desired extent.
A further limitation is the absence of a control group.
For this reason we cannot clearly attribute progress to
the specific DBT interventions. For instance, our results
demonstrate a decline in Borderline symptoms between
t0 and t1 possibly due to the knowledge of a therapy slot
with an expert in treating BPD, and the first therapy
sessions. This interpretation could be strengthened by
the comparison with a control group. However, it should
be noted that our results are comparable to those in other
effectiveness and efficacy studies.
The generalizability of the current results to all BPD
patients may be somewhat limited because exclusion
criteria were rather stringent to ensure comparability
with other outcome trials of DBT. Patients with current
substance dependence, acute suicidality, and psychotic
symptoms are usually not treated in outpatient settings in
Germany.
To this date, it is quite difficult for patients with BPD
in Germany to find a therapist who is willing to offer
psychotherapeutic treatment. Therefore, it can be assumed
that a number of patients originally took part in the study
in order to obtain a therapy slot. Some of them may have
lost interest in the research setting once they had
started their treatment and may thus have dropped
out of the protocol. As the pre-assessment scores (t0)
on the dependent variables did not differ from those
of the completers, an impact of psychopathology on
the dropout behavior can be ruled out.Conclusions
To summarize, by using outpatient DBT under routine
health care conditions in Germany significant im-
provement of psychopathology in borderline patients
was observed. In line with the results of other effec-
tiveness studies by Comtois et al. [24], Friedrich et al.
[25], Hjalmarsson et al. [26], and Pasieczny & Conner
[27], our data suggest that DBT treatment in routine
health care is efficient and its outcome is comparable to
that of RCTs.
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